bpc-157 protocol duration Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved Size:Full AOD-9604 | 99%+ Pure Glucose-dependent insulinotropic polypeptide
SKU: 41511242824
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 5 - Sep 10
























